NJ OTC Drug Marketing - State Board of Pharmacy
New Jersey and federal law bar false or misleading OTC drug ads, including cure claims, implied prescription strength, guaranteed or instant relief and misleading endorsements.
15 U.S.C. § 52; 21 CFR 330.1, 201.66; 16 CFR 255; N.J.S.A. 56:8-2